Comvita (CVT) Stock Overview
Engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CVT Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Comvita Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$0.51 |
| 52 Week High | NZ$0.84 |
| 52 Week Low | NZ$0.43 |
| Beta | 0.15 |
| 1 Month Change | -3.77% |
| 3 Month Change | -32.89% |
| 1 Year Change | -37.80% |
| 3 Year Change | -84.11% |
| 5 Year Change | -83.55% |
| Change since IPO | -76.82% |
Recent News & Updates
Recent updates
Health Check: How Prudently Does Comvita (NZSE:CVT) Use Debt?
Sep 04
Here's Why Comvita (NZSE:CVT) Is Weighed Down By Its Debt Load
Mar 21Comvita Limited's (NZSE:CVT) 26% Dip In Price Shows Sentiment Is Matching Earnings
Feb 05A Look At The Fair Value Of Comvita Limited (NZSE:CVT)
Nov 27These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well
Mar 25We Think Comvita's (NZSE:CVT) Robust Earnings Are Conservative
Mar 04Is It Too Late To Consider Buying Comvita Limited (NZSE:CVT)?
Mar 03Have Insiders Been Buying Comvita Limited (NZSE:CVT) Shares This Year?
Jan 29How Much Did Comvita's(NZSE:CVT) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 22Could The Comvita Limited (NZSE:CVT) Ownership Structure Tell Us Something Useful?
Nov 25
Shareholder Returns
| CVT | NZ Personal Products | NZ Market | |
|---|---|---|---|
| 7D | 2.0% | 1.0% | -0.6% |
| 1Y | -37.8% | -18.7% | 3.7% |
Return vs Industry: CVT underperformed the NZ Personal Products industry which returned -18.7% over the past year.
Return vs Market: CVT underperformed the NZ Market which returned 3.7% over the past year.
Price Volatility
| CVT volatility | |
|---|---|
| CVT Average Weekly Movement | 7.3% |
| Personal Products Industry Average Movement | 8.8% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in NZ Market | 7.7% |
| 10% least volatile stocks in NZ Market | 2.4% |
Stable Share Price: CVT's share price has been volatile over the past 3 months compared to the NZ market.
Volatility Over Time: CVT's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of NZ stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 400 | Karl Gradon | www.comvita.co.nz |
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities.
Comvita Limited Fundamentals Summary
| CVT fundamental statistics | |
|---|---|
| Market cap | NZ$35.99m |
| Earnings (TTM) | -NZ$104.76m |
| Revenue (TTM) | NZ$192.43m |
Is CVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVT income statement (TTM) | |
|---|---|
| Revenue | NZ$192.43m |
| Cost of Revenue | NZ$109.73m |
| Gross Profit | NZ$82.70m |
| Other Expenses | NZ$187.46m |
| Earnings | -NZ$104.76m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.48 |
| Gross Margin | 42.98% |
| Net Profit Margin | -54.44% |
| Debt/Equity Ratio | 130.0% |
How did CVT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/15 01:24 |
| End of Day Share Price | 2025/12/15 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Comvita Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Allbon | Deutsche Bank |
| Moira Daw | Edison Investment Research |
| Guy Edward Hooper | Jarden Limited |